Passionate Founder & Principal of Lyra Global, a Paris-based consultancy specializing in public affairs, strategic communications, and investor relations. With a robust background navigating heavily regulated industries and bringing first-in-class products to market, I'm committed to driving meaningful impact for businesses, governments and organizations worldwide. Incorporated in both France and the United States, Lyra Global is a bridge between continents, cultures, and markets.

As an Advisor to Loyal VC, support a diverse network of 400+ high-potential entrepreneurs across 60+ countries. Loyal VC, a semi-liquid, diversified global venture fund, invests in INSEAD alumni and top grads from the Founder Institute. Loyal's unique model offers founders strategic support and investors preferred access to top deals. With its innovative approach, Loyal has bypassed Y Combinator and now stands alongside Sequoia Capital as one of the most active early-stage investors globally.

• Recruited into Oxitec’s leadership to lead public-facing advocacy, policy, and engagement for public health and sustainable agriculture products worldwide.• Successfully launched first self-limiting mosquito project in the United States, lauded as globally significant and covered extensively in the international press.• While leading company’s communications achieved a shift in media coverage from 19% to 92% positive in less than two years, reaching an audience of almost 3 billion with over 1,100 published stories.• Navigated narrative pivot to sustainability with endorsement of conservation and environmental groups.

• Developed policy positions for next generation gene and cellular therapies including decentralized manufacturing facilitation, pricing and reimbursement.• Liaised with patient and disease advocacy groups to raise awareness of CAR-T therapies and to support patient recruitment for trials.

• Led global regulatory policy, government affairs and advocacy functions in the United States and worldwide in support of Intrexon business units and subsidiaries to expedite government approvals and mission critical government actions for company's full portfolio of first-in-class products.• Engaged external stakeholders, policy influencers and industry peers to advance policy priorities and commercial objectives for Intrexon’s innovative health and agriculture biotechnology products.• Led federal, state, local and grassroots advocacy and stakeholder engagement in support of U.S. Environmental Protection Agency (EPA) approval and U.S. Centers for Disease Control (CDC) funding for self-limiting mosquitoes.

• Led engagements with multilateral institutions including the World Health Organization (WHO), Pan-American Health Organization (PAHO), World Bank and Inter-American Development Bank to create a positive policy environment for full commercialization and ensure product funding streams. • Led coalition, policy development and advocacy efforts for innovative vector control tool policies to support malaria and neglected tropical disease reduction goals.• Advised on emerging intellectual property and patent threats.• Monitored policy and government funding priorities for vaccine development.• Developed policy positions and global market access strategies for livestock genetics and gene-edited and genetically engineered plant and animal products, advocated for expedient commercialization.

• Recruited to co-launch publicly traded Intrexon Corporation’s domestic U.S. and global government affairs department, worked closely with C-suite.• Developed and implemented policy priorities and strategic plans across agriculture, consumer products, energy, environment and health business units.• Successfully lobbied U.S. Congress for Emergency Use Authority designation of U.S. Food & Drug Administration (FDA) regulated Animal Drug.

Global project lead for benchmarking study of various country patent offices.

Advised on biologics, biosimilars and vaccines regulatory policy.

• Developed and executed international strategic plan, including organizing and conducting BIO advocacy on key international regulatory, trade, reimbursement and intellectual property (IP) issues.• As the BIO lead for Latin America, worked with BIO’s members across the food & agriculture, industrial & environmental and health sectors to establish priority advocacy areas for the region, with corresponding goals and metrics, and strategically implemented plan.• Spearheaded member consensus-building, drafting and final submission process for dozens of global public and private commenting processes covering biologics, biosimilars and clinical trials regulations.• Created a formalized task force with the Brazilian Federal Government’s National Committee on Biotechnology (CNB). Through this relationship, BIO was invited to lead the first-ever Biotech Patent Examiner Workshop held in Brazil and assisted with reform of Brazil's bioprospecting and genetic resources regulations.

• Guided market development and regulatory compliance for agricultural and industrial products and services, including U.S. labeling requirements for food products.• Assisted clients with World Trade Organization (WTO) case preparation, particularly involving the Sanitary and Phytosanitary (SPS) Agreement.• Contracted by the United Nations International Trade Centre to lead a week-long seminar for the senior management of APEX-Brasil, Brazil’s lead export promotion and investment agency.• Contracted by the Inter-American Development Bank, Inter-American Investment Corporation and AgExport to lead technical assistance workshops for Central American companies exporting to the U.S.• Worked extensively with Office of Foreign Assets Control (OFAC) regulations, especially Cuba Sanctions and Special Designated Nationals (SDN) List compliance. Led an OFAC-compliant trade mission of agricultural producers, exporters and service providers to Havana, Cuba.

• Counseled on U.S.-Colombia Trade Promotion Agreement (TPA).• Responded to U.S. industry TPA concerns and questions, including Tariff Rate Quota provisions and phase-out periods.• Provided analysis on CAFTA-DR and NAFTA.• Advised on regional legal systems and politics.

• Managed regional judicial reform and research agenda.• Teaching responsibilities with the Levin College of Law, Warrington College of Business, Center for Latin American Studies and Department of Political Science.

• Awarded a Fulbright Scholarship to assist in the design and evaluation of Chile’s judicial reform process in the areas of commercial and criminal law, in accordance with the requirements of the U.S. - Chile Free Trade Agreement (FTA) and including intellectual property rights protections.